Oncotelic Therapeutics, Inc. Employee Stock Ownership Plan (ESOP), Compensation Expense
Oncotelic Therapeutics, Inc. (OTLC) reported Employee Stock Ownership Plan (ESOP), Compensation Expense of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense · last filed 2013-03-15
- Oncotelic Therapeutics, Inc. employee stock ownership plan (esop), compensation expense for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Oncotelic Therapeutics, Inc. employee stock ownership plan (esop), compensation expense for fiscal 2011 was $2.00K, a 75.00% decline from fiscal 2010.
- Oncotelic Therapeutics, Inc. employee stock ownership plan (esop), compensation expense for fiscal 2010 was $8.00K.
| Period end | Employee Stock Ownership Plan (ESOP), Compensation Expense 12 month |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-15 |
| 2011-12-31 | $2.00K 10-K · filed 2013-03-15 |
| 2010-12-31 | $8.00K 10-K · filed 2013-03-15 |